Clinical Trials
Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial
Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced that NVX-CoV2373, its protein-based COVID-19 vaccine candidate, met the primary endpoint, with...
News
COVID-19 Vaccine AstraZeneca authorised for use in the EU
AstraZeneca’s COVID-19 vaccine has been granted a conditional marketing authorisation (CMA) in the EU for active immunisation to prevent COVID-19 caused by SARS-CoV-2, in individuals...
Press Releases
Novartis signs initial agreement to provide manufacturing capacity for Pfizer-BioNTech COVID-19 vaccine
Novartis announced that it has signed an initial agreement to leverage its manufacturing capacity and capabilities in order to address the COVID-19 pandemic by supporting...
News
Elasmogen identifies potential vaccine candidates to fight Covid-19
Elasmogen Ltd, the pioneering biopharmaceutical company leading the development of VNAR and soloMERTM biologics, announces a significant breakthrough in the identification of next-generation protein-based drugs...
News
COVID-19 vaccine: Bharat Biotech set to dispatch first consignment of Covaxin
Hyderabad, Bharat Biotech, which has received Emergency Use Authorisation approval from theDrug Controller General of Indiafor its COVID-19 vaccine Covaxin, is set to dispatch it...
News
Bharat Biotech signs agreement with Precisa Medicamentos to supply Covaxin to Brazil
Bharat Biotech announced that it has signed an agreement with Precisa Medicamentos for the supplies of COVAXIN™ to Brazil.
A team from Precisa Medicamentos has visited...
News
UNICEF, WHO, IFRC and MSF announce the establishment of a global Ebola vaccine stockpile
The four leading international health and humanitarian organizations announced today the establishment of a global Ebola vaccine stockpile to ensure outbreak response.
The effort to establish...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.